Christopher A Price

US Patent:

6571357, May 27, 2003

Filed:

Apr 29, 2000

Appl. No.:

09/563006

Inventors:

Matthew A. Martin - East Palo Alto CA
Everett Basham - Sunnyvale CA
Christopher D. Price - Campbell CA

Assignee:

Hewlett-Packard Development Company, L.P. - Houston TX

International Classification:

H02H 305

US Classification:

714 28, 714 29, 714738, 714742, 703 23, 703 24, 703 25

Abstract:

The application discloses a system and method for providing a compact and high speed mechanism for emulating an ASIC or other chip operating within a large computing system environment for diagnostic purposes. A two step process is disclosed for generating data patterns for fully exercising a chip and to then transmit these data patterns at a high frequency to a system under test. In phase one, a pattern generator preferably transmits test pattern data at a first frequency to a memory storage device. In phase two, the memory storage device is enabled to transmit the stored test pattern data at a high frequency to a system under test. Buffering the test pattern data in this manner enables the inventive system to bypass the data transmission speed limitation of the pattern generator while still employing the test patterns created by the pattern generator and to thereby test the system under test under high speed operating conditions.

US Patent:

8198242, Jun 12, 2012

Filed:

May 20, 2010

Appl. No.:

12/784117

Inventors:

Daniel J. Wendt - Walnut Creek CA, US
Shinong Long - Milpitas CA, US
Sianna Castillo - San Francisco CA, US
Christopher P. Price - Kentfield CA, US
Michel C. Vellard - San Rafael CA, US
Augustus O. Okhamafe - Concord CA, US

Assignee:

Biomarin Pharmaceutical Inc. - Novato CA

International Classification:

A61K 38/22
A61K 38/00
A61K 38/16
C12P 21/06
C12P 21/04
C07K 5/00

US Classification:

514 124, 514 167, 514 213, 435 694, 435 697, 435 712, 530324

Abstract:

The present disclosure provides variants of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising CNP variants, and methods of making CNP variants. The CNP variants are useful as therapeutic agents for the treatment of diseases responsive to CNP, including but not limited to bone-related disorders, such as skeletal dysplasias (e. g. , achondroplasia), and vascular smooth muscle disorders (e. g. , restenosis and arteriosclerosis).

US Patent:

8598121, Dec 3, 2013

Filed:

May 8, 2012

Appl. No.:

13/466672

Inventors:

Daniel J. Wendt - Walnut Creek CA, US
Shinong Long - Milpitas CA, US
Sianna Castillo - San Francisco CA, US
Christopher P. Price - Kentfield CA, US
Michel Claude Vellard - San Rafael CA, US
Augustus O. Okhamafe - Concord CA, US

Assignee:

Biomarin Pharmaceutical Inc. - Novato CA

International Classification:

A61K 38/22
A61K 38/00
A61K 38/16
C12P 21/04

US Classification:

514 124, 514 167, 514 213, 435 694, 435 697, 435 701, 530324

Abstract:

The present disclosure provides variants of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising CNP variants, and methods of making CNP variants. The CNP variants are useful as therapeutic agents for the treatment of diseases responsive to CNP, including but not limited to bone-related disorders, such as skeletal dysplasias (e. g. , achondroplasia), and vascular smooth muscle disorders (e. g. , restenosis and arteriosclerosis).